InflaRx IFRX
NASDAQ IFRX
$2.10 +0.08 (+3.96%)
At close: Aug 21, 2026 · 4:00 PM EDT

InflaRx (IFRX) Goodwill & Intangibles (2016 - 2026)

InflaRx (IFRX) posted Goodwill & Intangibles of $53382.5 for Q1 2026, up 8.53% sequentially from $49186.7 in Q4 2025, and down 6.26% YoY from $56944.8 in Q1 2025.

InflaRx (IFRX) Goodwill & Intangibles (2016 - 2026) Analysis & Trends

InflaRx has reported Goodwill & Intangibles for 11 years, with the latest figure at $53382.5 in Q1 2026.

  • Quarterly Goodwill & Intangibles fell 6.26% year-over-year to $53382.5 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $53382.5 (down 6.26% YoY) and the FY2025 annual result came in at $47740.2, down 13.14% from the prior year.
  • Goodwill & Intangibles grew to $53382.5 in Q1 2026 per IFRX's latest filing, from $49186.7 in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $798462.5 in Q4 2023 and troughed at $48136.1 in Q3 2024.
  • A 5-year average of $171076.5 and a median of $56944.8 in 2025 frame the typical range for Goodwill & Intangibles.
  • The sharpest annual moves came in 2024 and 2025: Goodwill & Intangibles sank 93.2% in 2024, then increased 17.36% in 2025.
  • Over 5 years, Goodwill & Intangibles stood at $737893.9 in 2022, then gained by 8.21% to $798462.5 in 2023, then tumbled by 93.2% to $54264.3 in 2024, then retreated by 9.36% to $49186.7 in 2025, then increased by 8.53% to $53382.5 in 2026.
  • According to Business Quant data, Goodwill & Intangibles over the past three periods registered $53382.5, $49186.7, and $53988.1 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 InflaRx 140.30 Mn -43.96 Mn 2.74 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 53,382.49
Dec 31, 2025 49,186.66
Sep 30, 2025 53,988.13
Jun 30, 2025 56,717.97
Mar 31, 2025 56,944.82
Dec 31, 2024 54,264.34
Sep 30, 2024 48,136.06
Jun 30, 2024 48,326.41
Mar 31, 2024 56,648.33
Dec 31, 2023 798,462.54
Sep 30, 2023 72,646.00
Jun 30, 2023 98,862.36
Mar 31, 2023 123,270.09
Dec 31, 2022 737,893.91
Sep 30, 2022 164,311.41
Jun 30, 2022 199,772.22
Mar 31, 2022 235,486.66
Dec 31, 2021 824,736.71
Sep 30, 2021 309,729.20
Jun 30, 2021 351,609.93